Publication number: 20230125667
Abstract: The present disclosure is concerned with TDZD analogs for the treatment of various neurodegenerative diseases such as sarcopenia, supranuclear palsy, Alzheimer's disease, Parkinson's disease, Huntington's disease, and dementia, and various cancers such as, for example, sarcomas, carcinomas, hematological cancers, solid tumors, breast cancer, cervical cancer, gastrointestinal cancer, colorectal cancer, brain cancer, skin cancer, prostate cancer, ovarian cancer, bladder cancer, thyroid cancer, testicular cancer, pancreatic cancer, endometrial cancer, melanomas, gliomas, leukemias, lymphomas, chronic myeloproliferative disorders, myelodysplastic syndromes, myeloproliferative neoplasms, and plasma cell neoplasms (myelomas). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Application
Filed:
February 12, 2021
Publication date:
April 27, 2023
Inventors:
Suresh Kuarm Bowroju, Peter Crooks, Narsimha Penthalla, Srinivas Ayyadevara, Monica Guzman, Robert J. J. Shmokler Reis, Eloisi Lopes, Samuel Kakraba